Mark Collen

Summary

Publications

  1. ncbi The Fourth Amendment and random drug testing of people with chronic pain
    Mark Collen
    PAIN Exhibit, Sacramento, California, USA
    J Pain Palliat Care Pharmacother 25:42-8. 2011
  2. ncbi Profit-driven drug testing
    Mark Collen
    PainExhibit com, Sacramento, California 95826, USA
    J Pain Palliat Care Pharmacother 26:13-7. 2012
  3. ncbi Prescribing cannabis for harm reduction
    Mark Collen
    PainExhibit, COM, 9008 El Cajon Way, 4, Sacramento, CA, 95826, USA
    Harm Reduct J 9:1. 2012
  4. ncbi Life of pain, life of pleasure: pain from the patients' perspective--the evolution of the PAIN exhibit
    Mark Collen
    Sacramento, CA, 95826, USA
    J Pain Palliat Care Pharmacother 19:45-52. 2005
  5. ncbi Analysis of controlled substance agreements from private practice physicians
    Mark Collen
    PAIN Exhibit, Sacramento, CA 95826, USA
    J Pain Palliat Care Pharmacother 23:357-64. 2009
  6. ncbi In my opinion... opioid tolerance
    Mark Collen
    J Pain Palliat Care Pharmacother 21:35-7. 2007
  7. ncbi More on opioid tolerance
    Mark Collen
    J Pain Palliat Care Pharmacother 21:89. 2007

Detail Information

Publications7

  1. ncbi The Fourth Amendment and random drug testing of people with chronic pain
    Mark Collen
    PAIN Exhibit, Sacramento, California, USA
    J Pain Palliat Care Pharmacother 25:42-8. 2011
    ..Issues discussed include consent, circumstantial coercion, and "special needs" searches...
  2. ncbi Profit-driven drug testing
    Mark Collen
    PainExhibit com, Sacramento, California 95826, USA
    J Pain Palliat Care Pharmacother 26:13-7. 2012
    ..This article suggests profits also drive physician drug-testing behavior and evidence is offered, including an exploration of Medicare reimbursement incentives and kickbacks for drug testing...
  3. ncbi Prescribing cannabis for harm reduction
    Mark Collen
    PainExhibit, COM, 9008 El Cajon Way, 4, Sacramento, CA, 95826, USA
    Harm Reduct J 9:1. 2012
    ..This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications...
  4. ncbi Life of pain, life of pleasure: pain from the patients' perspective--the evolution of the PAIN exhibit
    Mark Collen
    Sacramento, CA, 95826, USA
    J Pain Palliat Care Pharmacother 19:45-52. 2005
    ..com are described. Guidance for clinicians form the patient perspective is provided...
  5. ncbi Analysis of controlled substance agreements from private practice physicians
    Mark Collen
    PAIN Exhibit, Sacramento, CA 95826, USA
    J Pain Palliat Care Pharmacother 23:357-64. 2009
    ....
  6. ncbi In my opinion... opioid tolerance
    Mark Collen
    J Pain Palliat Care Pharmacother 21:35-7. 2007
    ..The writer challenges the position of many clinicians and professional societies that tolerance to opioid analgesia usually is not a barrier to effective pain management. Implications for clinicians are presented...
  7. ncbi More on opioid tolerance
    Mark Collen
    J Pain Palliat Care Pharmacother 21:89. 2007